Decomposing compounds enables reconstruction of interaction fingerprints for structure-based drug screening

被引：0
|
作者：
Melissa F. Adasme
Sarah Naomi Bolz
Ali Al-Fatlawi
Michael Schroeder
机构：
[1] Biotechnology Center (BIOTEC),
[2] CMCB,undefined
[3] Technische Universitat Dresden,undefined
来源：
Journal of Cheminformatics | / 14卷
关键词：
Fragments; Binding mode; Structural data; Non-covalent interactions; Interactions fingerprint;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Ligand docking and structure-based virtual screening in drug discovery
    Cavasotto, Claudio N.
    Orry, Andrew J. W.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (10) : 1006 - 1014
  • [22] Structure-based drug design identifies polythiophenes as antiprion compounds
    Herrmann, Uli S.
    Schuetz, Anne K.
    Shirani, Hamid
    Huang, Danzhi
    Saban, Dino
    Nuvolone, Mario
    Li, Bei
    Ballmer, Boris
    Aslund, Andreas K. O.
    Mason, Jeffrey J.
    Rushing, Elisabeth
    Budka, Herbert
    Nystrom, Sofie
    Hammarstrom, Per
    Boeckmann, Anja
    Caflisch, Amedeo
    Meier, Beat H.
    Nilsson, K. Peter R.
    Hornemann, Simone
    Aguzzi, Adriano
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (299)
  • [23] Structure-based drug screening and ligand-based drug screening toward protein-compound network
    Fukunishi, Yoshifunli
    COMPUTATION IN MODERN SCIENCE AND ENGINEERING VOL 2, PTS A AND B, 2007, 2 : 311 - 314
  • [24] Novel 3D fingerprints improve the odds of success in structure-based virtual screening
    Kireev, Dmitri
    Gao, Cen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [25] Identification of a novel class of small compounds with anti-tuberculosis activity by in silico structure-based drug screening
    Junichi Taira
    Koji Morita
    Shotaro Kawashima
    Tomohiro Umei
    Hiroki Baba
    Taira Maruoka
    Hideyuki Komatsu
    Hiroshi Sakamoto
    James C Sacchettini
    Shunsuke Aoki
    The Journal of Antibiotics, 2017, 70 : 1057 - 1064
  • [26] Identification of a novel class of small compounds with anti-tuberculosis activity by in silico structure-based drug screening
    Taira, Junichi
    Morita, Koji
    Kawashima, Shotaro
    Umei, Tomohiro
    Baba, Hiroki
    Maruoka, Taira
    Komatsu, Hideyuki
    Sakamoto, Hiroshi
    Sacchettini, James C.
    Aoki, Shunsuke
    JOURNAL OF ANTIBIOTICS, 2017, 70 (11): : 1057 - 1064
  • [27] The role of virtual screening in computer aided structure-based drug design
    Branson, KM
    Smith, BJ
    AUSTRALIAN JOURNAL OF CHEMISTRY, 2004, 57 (11) : 1029 - 1037
  • [28] Interaction prediction in structure-based virtual screening using deep learning
    Gonczarek, Adam
    Tomczak, Jakub M.
    Zareba, Szymon
    Kaczmar, Joanna
    Dabrowski, Piotr
    Walczak, Michal J.
    COMPUTERS IN BIOLOGY AND MEDICINE, 2018, 100 : 253 - 258
  • [29] Ligand and structure-based virtual screening approaches in drug discovery: minireview
    da Rocha, Matheus Nunes
    de Sousa, Damiao Sampaio
    Mendes, Francisco Rogenio da Silva
    dos Santos, Helcio Silva
    Marinho, Gabrielle Silva
    Marinho, Marcia Machado
    Marinho, Emmanuel Silva
    MOLECULAR DIVERSITY, 2024,
  • [30] Structure-based drug screening for G-protein-coupled receptors
    Shoichet, Brian K.
    Kobilka, Brian K.
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2012, 33 (05) : 268 - 272
12345